Through studying the role of oxidative stress in hypertension, it has been determined that upregulation of ROS production is more likely to be a consequence of VEGF inhibitor-induced hypertension (Versmissen et al., 2019). This evidence concerns the gene VEGFA and hypertensive disorder.